There are 2789 resources available
400P - Baseline expression of RAD23B protein in circulating tumor cells correlates with complete pathological response of neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Presenter: Virgilio E Silva
Session: ePoster Display
401P - Translation of the IDEA trial into clinical practice: Evaluation of implementation of a new guideline
Presenter: Karlijn Rooijen van
Session: ePoster Display
402P - Chemoradiation versus less intensive treatments in stage I squamous cell carcinoma of the anal canal (SCCA)
Presenter: Rachel Riechelmann
Session: ePoster Display
417P - Liquid biopsy driven anti-EGFR rechallenge in metastatic colorectal cancer
Presenter: Marco Puzzoni
Session: ePoster Display
418P - Upfront primary tumour resection (UPTR) and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Presenter: Manuel Benavides
Session: ePoster Display
419P - XELOX/XELIRI alternative regimen as first-line treatment of metastatic colorectal cancer (CCRCTO-2: TROT): A phase II study
Presenter: YU HAN
Session: ePoster Display
420P - A single-arm, multicenter, phase II study of anlotinib combined with CAPEOX as first-line treatment in RAS/BRAF wild-type unresectable metastatic colorectal cancer (ALTER-C002)
Presenter: Kefeng Ding
Session: ePoster Display
421P - FOLFIRINOX with or without targeted therapy as first line for metastatic colorectal cancer: An AGEO multicenter real-world study
Presenter: Romain Varnier
Session: ePoster Display
422P - The efficacy and safety of irinotecan plus raltitrexed as second-line treatment in advanced colorectal cancer (ACC) patients: A summary analysis of a multicenter, phase II trial
Presenter: Xiujuan Qu
Session: ePoster Display